Together, this work suggests that SHPRH is a tumor suppressor gene in LUAD whose expression is associated with reduced LUAD development and more favorable prognosis and – coupled with its chromosomal location in a susceptibility locus and role in DNA damage tolerance – warrants further assessment as a potential biomarker for individuals at-risk of developing LUAD. The gene discussed is SHPRH; the disease is neoplasm.